|
Oct 9
|
Myriad signs five partnerships to study MRD testing in breast cancer
|
|
Oct 8
|
Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer
|
|
Oct 4
|
Myriad and Ultima to study UG 100 sequencing platform for genomics clinical tests
|
|
Oct 3
|
Myriad Genetics and Ultima Genomics to Explore the UG 100™ Sequencing Platform to Advance Clinical Test Offerings in Oncology and Reproductive Genomics
|
|
Oct 1
|
Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
|
|
Oct 1
|
BMRN or MYGN: Which Is the Better Value Stock Right Now?
|
|
Sep 19
|
Myriad Genetics Has Many Opportunities for Growth, Needs Sustained Execution, Morgan Stanley Says
|
|
Sep 18
|
Here's Why Myriad Genetics (MYGN) is a Strong Momentum Stock
|
|
Sep 18
|
Myriad Genetics to Share New Data Highlighting Genetic Testing Advancements at 2024 National Society of Genetic Counselors Annual Conference
|
|
Sep 17
|
Should You Continue to Retain MYGN Stock in Your Portfolio?
|
|
Sep 5
|
Myriad Genetics to Host Investor Event on October 9, 2024
|
|
Sep 5
|
Insider Sale: Director Colleen Reitan Sells Shares of Myriad Genetics Inc (MYGN)
|
|
Sep 4
|
New Partnerships to Aid Myriad Genetics Stock Amid Macro Issues
|
|
Aug 30
|
Why Myriad Genetics (MYGN) is a Top Momentum Stock for the Long-Term
|
|
Jul 30
|
Myriad Genetics to Release Second Quarter 2024 Financial Results on August 6, 2024
|
|
Jun 24
|
Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election
|
|
Jun 21
|
An Intrinsic Calculation For Myriad Genetics, Inc. (NASDAQ:MYGN) Suggests It's 30% Undervalued
|
|
Jun 12
|
Myriad Genetics (MYGN) and GSK Unite to Boost HRD Testing
|
|
Jun 11
|
Myriad Genetics (MYGN) Banks on Innovation Amid Macro Woes
|
|
Jun 11
|
Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries
|